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ABSTRACT
Understanding the structure-function relationship of membrane receptors is essential
to comprehend the crosstalk between key signaling pathways.

Aberrant trans-

activation between receptors can lead to tumorigenesis. Two of these receptors
known to be involved in cancer development are receptor tyrosine kinases (RTKs),
RON (Recepteur d'Origine Nantais) and EGFR (Epidermal Growth Factor Receptor).
There has been evidence of heterodimerization and crosstalk between these two
receptors based on co-immunoprecipitation, however the structural requirements
behind these interactions remain unknown. Structural studies could provide insights
into these RTKs’ modes of dimerization and structure-function relationship. However,
structural studies of full-length membrane proteins are often difficult due to poor
solubility of the hydrophobic transmembrane domains. This affects protein structure
and functionality. The use of nanodiscs for protein structural studies helps provide a
native-like environment for membrane proteins, helping to avoid denaturing and
aggregation, as well as providing a homogeneous size which makes them ideal for
imaging techniques. In this work, we focus on optimizing a nanodisc assembly
protocol to incorporate full-length RON and EGFR receptors into nanodiscs, as well
as developing techniques to detect protein incorporation into these nanodiscs, which
would ultimately facilitate structural studies for RON and EGFR heterodimerization.
These studies could provide a mechanistic justification for novel targeted therapies in
cancer.
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CHAPTER 1: INTRODUCTION
1.1.

Receptor Tyrosine Kinases signaling and function

Receptor Tyrosine Kinases (RTKs) are cell-surface receptors that are essential in
multiple cell processes, such as metabolism, survival, proliferation, differentiation,
motility, and cell cycle control (Ullrich, 1990; Blume-Jensen 2001). RTKs are singlepass transmembrane proteins that bind ligands (Maruyama, 2014). Humans have 58
known RTKs divided in 20 subfamilies with similar molecular structures (Lemmon,
2010). The general structure of an RTK consists of an extracellular ligand-binding
domain, a single helix transmembrane domain, and a cytoplasmic region containing
a tyrosine kinase domain as well as carboxy-terminal and juxtamembrane regulatory
regions (Figure 1).

Figure 1. General RTK structure and ligand-based dimerization mode. RTK basic structure contains an
extracellular ligand-binding domain, a single-pass transmembrane domain, and a tyrosine kinase domain. Upon
ligand binding, kinases are activated and tyrosines are phosphorylated, which allows intracellular protein binding
and triggers several signaling pathways.

Phosphorylation of the tyrosine allows for communication of extracellular information
to intracellular signaling proteins. RTKs accomplish this function through activation of
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their protein kinase domain. In general, one
ligand binding to the extracellular domain
triggers receptor dimerization and leads to
activation (Figure 2). Association of the
extracellular region guides the intracellular
domains into dimeric conformation, bringing
their

kinase

domains

together

in

an

asymmetric dimer and thus increasing kinase
activity and producing phosphorylation of
tyrosine residues. Some of these tyrosine
residues help maintain active conformation of
the kinase, while some tyrosines act as
docking

sites

for

other

proteins

that

propagate signaling pathways (Ullrich, 1990;
Figure 2. EGFR and RON dimerization modes.
A. EGFR receptor-mediated dimerization.
EGFR dimerizes through the extracellular
domain after ligand binding, bringing the
kinase domains (KD) together and forming an
asymmetric dimer. In this case, the ligand
does not form part of the interface between
receptors (EGF in yellow). B. The modes or
RON dimerization are not entirely known. It is
thought that RON forms dimers in the absence
of ligand by overlapping ECDs. The orientation
of KDs upon dimerization is unknown. (MSP in
orange) C. “Activator-Receiver” model for
EGFR dimerization. This model establishes
allosteric activation by direct contact between
two KDs from two receptors. The Activator’s
C-lobe creates contact with the Receiver’s Nlobe, destabilizing autoinhibitory interactions
of the Receiver’s activation loop.

Lemmon 2010 Maruyama, 2014). Generally,
RTK dimerization occurs when two ligandbound monomers initiate signaling. However,
some RTKs are also thought to exist as preformed, inactive, dimers.
There

are

several

mechanisms

of

dimerization for RTK family members that
involve a combination of ligand-mediated and
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receptor-mediated components. Ligand-mediated interactions are the most
commonly known. These occur when a bivalent ligand interacts simultaneously with
two receptors, crosslinking them into a dimeric complex in which the two receptors
make no physical contact (Figure 1). Receptor-mediated dimerization involves
physical contact between receptors with no direct contribution from a ligand (Figure
2A). This type of dimerization has been identified in the Epidermal Growth Factor
Receptor (EGFR)/ErbB family (Lemmon, 2010). These receptors also display a type
of dimerization in which the ligand binds to two different sites within a single receptor
instead of crosslinking two receptors, causing a conformational change on the
extracellular region (Burgess, 2003). The crystal structure of the extracellular
domains of RON suggests that this RTK may form dimers by using both “receptormediated” and “ligand-mediated” interactions (Figure 2B) (Chao et al., 2012).
Furthermore, the orientation of the RON kinase domain upon dimerization is not well
defined, but it has been suggested that the C-terminal tail blocks the kinase domain
active site during the inactive state as for many other RTKs (Figure 2B – green line)
(Yokoyama et al., 2005).
In the case of crystalized EGFR kinase domain fragments, these can form an inactive
symmetric dimer and an active asymmetric dimer. The asymmetric dimer formed
between two kinase domains relies on an activator-receiver model, in which the
activator’s C-terminal lobe makes physical contact with the adjacent N-terminal lobe
of the receiver, causing a conformational change that activates the receiver kinase
domain (Figure 2C) (Maruyama, 2014). Studies where the activator/receiver
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interacting surfaces were mutated in the full-length receptors suggest that the
asymmetric dimer formation is important for activation of the full-length receptor
(Zhang et al., 2006).
Furthermore, RTK signaling is not only initiated by homodimers, but also by
heterodimers within a family such as heterodimerization of EGFR with ErbB2 (Li et al.,
2012), or with other families of RTKs. Crosstalk is referred to the influence of one
receptor on the signaling activity of a second heterologous receptor and its signaling
intermediates. We are interested in the crosstalk of EGFR and RON, two receptors
from different families with different apparent mechanisms of activation.

1.2.

RTK signaling in cancer research

RTK activity is highly regulated in normal cells, while dysregulation of these receptors
has been found in a wide range of cancers. In cancer cells, dysregulated activation of
RTKs is caused by gene amplification, mutations, gene re-arrangement, overexpression, or abnormal endocrine, autocrine, or paracrine stimulation of both
receptor and ligand (Takeuchi and Ito, 2011). RTKs dysregulation has been
correlated with the development and progression of a number of cancers, making
them a promising therapeutic target (Takeuchi and Ito, 2011; Prahallad, 2016).
Cancer and its connection to aberrant signaling of RTKs has driven the development
of drug therapies that inhibit or attenuate RTK activity (Lemmon, 2010).
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Resistance to therapies decreases survival rate for cancer patients. Cancer treatment
requires new strategies that can provide information behind the complexity of signal
transduction pathways and receptor crosstalk (Prahallad, 2016). Structural studies of
RTK crosstalk could provide some insight on how aberrant signaling influences the
development, progression, and resistance of cancer.

1.3.

EGFR and RON crosstalk

Heterogeneous receptor-receptor interactions play an important role in maintaining
cell functions by inducing specific intracellular signaling cascades (Peace, 2003). Two
RTKs, RON (Recepteur d'origine nantais) and EGFR are known to co-overexpress on
tumors, which results in crosstalk. However, the molecular mechanisms that facilitate
this interaction are unknown.
RON is a membrane receptor that binds macrophage-stimulating protein (MSP). The
RON receptor is synthesized as a single chain precursor of 185 kDa that is then
cleaved into its heterodimeric, mature form before it is trafficked to the cell membrane
(Peace, 2003).

The general structure of RON consists of an extracellular ligand-

binding domain, followed by a single-pass transmembrane domain and an intracellular
beta chain that contains a catalytic tyrosine kinase domain (Peace, 2003). It is known
to regulate inflammatory responses in skin, liver, and lung, as well as playing an
important role in ovarian development (Peace, 2003). RON is a member of the MET
family of RTKs, it is expressed in epithelial tissues, and plays an important role in
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cancer (Peace, 2003; Waltz, 1998; Benight and Waltz, 2012; Yokoyama et. al. 2005;
Stella et. al. 2018; Faham et. al., 2016; Kang et. al., 2015; Maggiora et. al., 1998).
Evidence of overexpression of RON and constitutive phosphorylation of this receptor
has been found in a number of epithelial human cancers, such as pancreatic, ovarian,
colon, and lung cancer (Maggiora, 1998; Chen, 1997). Cells overexpressing RON
have shown an increase in cell proliferation, migration, and branching
morphogenesis, all of which may play roles in cancer (Peace, 2003).
EGFR is present in a large number of tissue types, and it contributes to the regulation
of apoptosis, proliferation, migration, and differentiation (Sibilia, 1995). EGFR is
upregulated in different tumor types due to overexpression or upregulation of
signaling mediated by EGFR-ligand stimulation (Peace, 2003). EGFR is a single chain
glycoprotein of 180kDa. It consists of a ligand-binding extracellular domain, a singlepass transmembrane domain, and a cytoplasmic kinase domain. EGFR is a member
of the erbB family of RTKs and it is known to bind to several ligands, including the
epidermal growth factor (EGF) and the transforming growth factor alpha (TGF-α)
being the most common and abundant (Peace, 2003; Wells,1999).
Both RON and EGFR are highly expressed in many different tissues They are also
associated with cell motility and morphological changes that lead to branching
tubulogenesis (Peace, 2003). RON is known to interact with heterologous receptors,
and EGFR has been often described as a central player in crosstalk interactions
(Peace, 2003, Faham et. al., 2016). Co-immunoprecipitation studies indicate there
could be a direct interaction between EGFR and RON similar to other interactions
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within the EGFR family and the MET family. This could suggest there is a functional
and biochemical interaction between EGFR and RON that plays a role in cellular
processes leading to cancer (Ortiz-Zapater et al.,2017; Engelman et al., 2007).

1.4.

Structural studies: Nanodiscs

Studying structural and mechanistic properties of membrane proteins is often difficult.
Solubilization is important to maintain target proteins in a stable state that allows for
manipulation and analysis. The most common technique to solubilize membrane
proteins is through the use of detergents that form detergent-lipid-protein micelles
(Mi, 2008). However, the formation of micelles often interferes with a number of
assays and optical techniques, and the detergent tends to reduce protein activity as
they co-concentrate with the protein, which can lead to denaturation. This often
results in the use of protein fragments for structural studies through crystallography
that help determine extracellular domain and kinase domain interactions, as it is the
case with EGFR, and all four ErbB receptors (Bouyain S, 2005; Cho HS and Leahy
DJ, 2002; Cho HS et al., 2003; Ferguson KM et al., 2003; Garrett TP et al., 2003).
Many membrane proteins require specific types of lipids to maintain activity, and this
characteristic is not well mimicked by detergent micelles. Another approach to study
membrane proteins is liposomes that incorporate membrane proteins within the
bilayer. In this case, each side of the bilayer is compartmentalized (Sligar, 2016, Mi
et al., 2008), and the membrane protein is found in a more native state. However,
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liposomes are usually unstable and are difficult to prepare with a controlled size and
stoichiometry, generating a homogeneous sample (Sligar, 2016).
Nanodiscs offer a solution to some of these challenges by providing a defined-sized
native-like environment to membrane proteins that offers stability to the target protein.

Figure 3. Schematic of an assembled nanodisc.
(Top) Side view of an assembled nanodisc. A
phospholipid bilayer forms within two MSP belt
proteins. Nanodisc diameter depends on the belt
protein’s length, while nanodisc width is related to the
phospholipid’s chain length. (Left) Top view of an
assembled nanodisc. The phospholipids arrange in a
bilayer that is surrounded by two MSP belt proteins.
This provides a contained and homogeneous nativelike environment for membrane proteins.

Important structural information of membrane proteins can be obtained through a
variety of biophysical techniques. Critical structural data, such as protein-protein and
lipid-protein interactions, as well as detailed images of protein structure, can be
facilitated using nanodiscs (Denisov and Sligar, 2013). Nanodiscs provide a nativelike environment that increases protein stability and maintains their functionality by
preventing aggregation. Given that target proteins remain active and monodisperse
in nanodiscs, they are often used in x-ray crystallography, where nanodiscs are used
to collect substantial quantities of protein without aggregation (Denisov and Sligar,
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2013). Protein embedding into nanodiscs helps with storage and collection of active
membrane proteins or receptor fragments for subsequent functional studies.
Nanodiscs have been used for cryo- and negative staining electron microscopy (EM),
where the highly homogeneous size of nanodisc preparations help with structural
determination. Membrane proteins in nanodiscs are less susceptible to aggregation.
This characteristic helps preserve protein function and structure (Denisov and Sligar,
2013). Nanodiscs have been used to decipher the structure of the Tc Toxin, drug
efflux pumps, the magnesium channel, the ryanodine receptor, among others
(Gatsogiannis et al., 2016; Daury et al., 2016; Matthies et al., 2016; Efremov et al.,
2015; Xu et al., 2016; Shenkarev et al., 2018; Gao et al., 2016; Gogol et al., 2012).
Another use is nuclear magnetic resonance (NMR), a technique that is often used to
analyze soluble proteins and obtain structural data (Bax, 1989). Protein solution
methods usually limit the size of target protein for NMR analysis. Nanodiscs prevent
aggregation of membrane proteins and have a defined stoichiometry, making high
resolution studies possible (Denisov and Sligar, 2013). NMR techniques, such as
solution and solid-state NMR have relied on the use of nanodiscs to provide
information on membrane protein structure and function, as well as their interactions
with the lipid membrane. Nanodiscs have been used to understand the relationship
between the oncogenic protein KRas4b and the lipid bilayer, shedding some light on
protein conformational changes linked to protein-lipid interactions (Mazhab-Jafari,
2015; Hagn et al., 2018; Viennet et al., 2019).
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Nanodiscs can be fixed to surfaces without losing their structure. This makes them
great tools for single molecule studies, such as Atomic Force Microscopy (AFM),
single-molecule imaging, and fluorescence spectroscopy (Denisov and Sligar, 2013).
Nanodiscs have been used to incorporate K+ channel protein and study its dynamics
using single molecule fluorescence resonance energy transfer (FRET), showing that
the presence of PIP2 causes a conformational change in the channel that is consistent
with a “twist-shrink” structural model. In this case, nanodiscs provide a native-like lipid
bilayer (Sadler et al., 2016). Single-molecule force spectroscopy has relied on protein
incorporation into nanodiscs, including studies on the mechanical unfolding of
bacteriorhodopsin (Zocher et al.,2012). Nanodiscs have also been used for singlemolecule fluorescence and total internal reflection microscopy to monitor binding of
Nile Red and its effects on CYP3A4 embedded into nanodiscs (Nath et al., 2010).
Generally, spectroscopic methods, such as electron spin resonance, optical and
electron paramagnetic resonance spectroscopy, and resonance Raman are
fundamental to determine membrane protein functionality (Finkenwirth et al., 2015;
Luthra et al., 2013; Mak et al., 2015). The use of nanodiscs for these techniques
provides a bilayer that allows membrane proteins to maintain their functionality
(Denisov and Sligar, 2013). Membrane protein characterization through X-ray and
neutron scattering also benefit from the use of nanodiscs. Usually, these techniques
are limited by protein size and aggregation, as well as protein orientation, these issues
can be solved by using nanodiscs (Denisov and Sligar, 2013). Examples of these
include curdlan synthase, cytochrome P450, and the formation of functional trimers
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of bacteriorhodopsin (Periasamy et al., 2012; Skar-Gislinge et al., 2015; Bayburt et
al., 2006)
Nanodiscs are non-covalent assemblies of phospholipids and a membrane scaffold
protein (MSP), a genetically modified apolipoprotein (Borch, 2009; Sligar 2016). The
phospholipid acts as a bilayer domain while two MSP molecules wrap around the
edges of the discoidal structure in a belt-like configuration, each MSP covering the
hydrophobic alkyl chains of each leaflet (Figure 3) (Sligar,2016).
The membrane scaffold protein (MSP) is based on the sequence of human
apolipoprotein A1 (ApoA-1), which is related to the serum apolipoproteins that are
the primary component of high-density lipoproteins (Borch, 2009; Sligar, 2016). MSP
is an amphipathic helical belt protein that wraps around a lipid bilayer of defined
number of lipid molecules. It is formed by the truncation or repetition of the 11- and
22-residue stretches of the ApoA-1 punctuated by proline and glycine, and its length
can be increased by adding additional 22-mer repeat units (Sligar, 2016; Siuda and
Tielman, 2015). MSP is often expressed in E. coli from a synthetic gene that can
include various affinity tags and different lengths that control overall nanodisc size. In
our studies, we use His-tagged MSPs.
The lipid bilayer that forms the nanodisc can be composed of different mixtures of
phospholipids and other components, such as cholesterol. The membrane can be
tailored in composition to suit the protein of interest or study the effects of the bilayer
environment on the function of the membrane protein.
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Nanodisc size is strictly related to MSP length, area per phospholipid, and number of
phospholipids. This means that a defined phospholipid to MSP ratio during assembly
leads to homogeneous nanodisc size (Borch, 2009). If the lipid ratio is too high,
populations of large MSP-lipid aggregates will form along with the nanodiscs, this is
due to the fact that a higher area to perimeter is needed to match the length of
hydrophobic MSP belt to the amount of total phospholipid (Sligar, 2016; Bayburt TH,
Grinkova YV, Sligar SG, 2002). If lipid to MSP ratio is too low, conditions are
unfavorable for disc formation and MSP will form MSP-rich aggregates or nanodiscs
that are prone to deformation (Sligar, 2016; Bayburt TH, Grinkova YV, Sligar SG,
2002)
To form nanodiscs, first detergent, phospholipid micelles and MSP are mixed
together. Self-assembly of nanodiscs is then triggered by detergent removal.
Detergent can be removed through adsorption treatment using porous polystyrene
beads or through dialysis. Nanodiscs form most efficiently near the phospholipid
phase transition temperature, because of the effects of phase behavior on size and
organization of the phospholipid/detergent micelles (Borch, 2009; Sligar, 2016). To
incorporate a membrane protein of interest into nanodiscs, the purified protein is
usually pre-solubilized with a compatible detergent such as DDM and is mixed with
the nanodisc components prior to detergent removal. Once the detergent is removed,
membrane protein-lipid and lipid-lipid interactions occur as the bilayer is formed
incorporating the protein within the nanodisc and keeping it in a native-like
configuration (Borch, 2009; Sligar, 2016).
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Specific Aims
Protein structural studies provide mechanistic insight into receptor conformational
changes and interaction interfaces that initiate important signaling pathways. These
pathways are triggered by proteins whose mechanisms of dimerization and structurefunction are not entirely defined. The structure of the epidermal growth factor receptor
(EGFR), its activation by ligand, and subsequent homodimerization have been well
studied by our group and others. However, recent evidence of crosstalk between
EGFR and other receptors, such as the Met receptor family, has led us to explore how
these different receptors might interact. Aberrant activation of RON and EGFR due to
crosstalk, can lead to tumorigenesis. Although these receptors can be coimmunoprecipitated, the structural requirements for their interactions are not known.
Throughout this work we focus on developing a nanodisc assembly protocol that
allows us to incorporate full-length RON or EGFR receptors into nanodiscs, ultimately
to facilitate studies of RON and EGFR dimerization. To achieve this, this work has two
specific aims:
Aim 1: Optimize a nanodisc assembly and protein incorporation method for full-length
transmembrane proteins
Membrane protein structural studies are often difficult due to the lack of a proper
environment for protein solubilization and receptor size. The general structure of
EGFR has been determined by crystallization using individual domains of the receptor.
Structural and function studies on membrane proteins often use micelles to
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incorporate these proteins, but these are oftentimes large and unstable. Nanodiscs
provide a membrane-like environment that allows for solubilization of proteins in a
native setting of homogeneous size that maintains the receptor’s conformation and
functionality. Nanodiscs have been used previously to solubilize many proteins, such
as Rhodospin, Neurokinin 1 Receptor (NK1R), Integrin-linked kinase (ILK), including
EGFR (Bayburt et. al., 2007; Gao et. al., 2012; Dobreva et. al., 2008; Mi et. al., 2008).
We rationalized that by optimizing the nanodisc size and lipid content, we could
optimize the incorporation of proteins into the nanodisc. This is especially important
in the case of receptor dimers that require a larger lipid surface. Considering this, we
tested two belt-proteins that form nanodiscs of two different sizes, and we tested
multiple phospholipids of different chain lengths to see if these influence protein
incorporation.
Aim 2: Determine a method to best detect protein incorporation into nanodiscs
Identifying protein incorporation into nanodiscs is often achieved through sizeexclusion chromatography or native gel electrophoresis. In this work, we had the goal
of finding a reliable method to detect receptor incorporation in nanodiscs, particularly
in small preparations. We have compared the use of size-exclusion chromatography,
gel electrophoresis, affinity purification of proteins, and advanced microscopy
techniques to detect protein incorporation.
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CHAPTER 2: METHODS
HEK293 Protein production
HEK293 adherent cells were transfected with recombinant proteins, Full-length RONmNG-SBP (mNeonGreen-Streptavidin Binding Peptide) and Full-length EGFR-SBP
(Streptavidin Binding Peptide) and established. Cells were cultured for at least two
passages to allow recovery from thaw, and G418 was used as selective agent after
thaw. Initially, cells were cultured in a T75 and exponentially subcultured into 6-8 T175
before harvest.

Cycloheximide Treatment
HEK293 cells transfected with full-length RON were treated with a 50 mg/mL solution
of Cycloheximide in DMSO for 4 hours at 37 °C before harvest. Cells were harvested
once reaching 95% confluency using a cell scrapper and were lysed (20 mM Tris pH
8.0, 400 mM NaCl, 10% glycerol, 0.2% DDM, 1 mM EDTA).

Transient transfection of recombinant proteins in Expi293F cells
Expi293F cells (Gibco A14635) are grown as suspension cultures in a 37oC incubator
at 8% CO2 with shaking at 125 rpm. Cells were thawed and grown for at least two
passages to allow them to recover. Cells were prepared for transfection by seeding
them at a density of 3x106 cells/mL in a 30 mL culture. These cells were then
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transfected as per the manufacturers protocol by mixing 30 g of plasmid with
ExpiFectamine 293 reagent (Gibco) to form lipid-DNA complexes. Expifectamine
Enhancer Reagents 1 and 2 were added 24 hours after transfection. The transfected
cells were incubated for an additional 2 days before harvest.

Test for protein expression
A 500 L aliquot of the transfected cells was fixed and labeled with fluorescent
antibodies for confocal imaging to observe protein expression and localization. Half
of the aliquoted cells were fixed in 2% PFA-PBS for 20 min at room temperature, while
the remaining half were permeabilized in 0.05% Triton X-100/Hoechst. Cells were
labeled with primary antibodies to label RON (RON β-E3 (sc-74588), Santa Cruz) or
EGFR (EGFR XP, Cell Signaling D38B1) or with fluorescently labeled ligand, EGFA488. Labeling agents were added directly to the media and incubated for 1 hr in at
a dilution of 1:100 dilution in 3% BSA-TBS. Cells were incubated with secondary
antibodies diluted at 1:200 in 3% BSA-TBS. Cells were washed with PBS and
centrifuged to recover the pellet. 2µL of the cell pellet were mounted on a slide with
Prolong Gold and cured overnight at room temperature.

Protein purification
Transfected cells were lysed (20 mM Tris pH 8.0, 400 mM NaCl, 10% glycerol, 0.2%
DDM, 1 mM EDTA) and left on ice for 1 hour with vortexing every 5 min. The lysate
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went through three freeze-thaw cycles at -80 ˚C, then was ultracentrifuged and the
cell debris pellet was discarded.
Protein was purified using the InterPlay Mammalian TAP system from Agilent
(240104) that uses Streptavidin resin to bind SBP-tagged proteins. The streptavidin
resin (Agilent - 240105) was washed 3 times using Streptavidin Binding Buffer
containing 20 mM Tris pH 8.0, 400 mM NaCl, 10% glycerol, 0.1% DDM, 1 mM EDTA,
and 10 mM 2-Mercaptoethanol. The lysate was then separated into individual 1 mL
aliquots, and 100 L of washed resin was added. The mixture was incubated
overnight at 4o C with gentle shaking. After centrifugation and removal of the
supernatant, each aliquot was washed with Streptavidin Binding Buffer (20 mM Tris
pH 8.0, 400 mM NaCl, 10% glycerol, 0.1% DDM, 1 mM EDTA, 10 mM 2Mercaptoethanol). Samples were incubated for 2 hrs. in Streptavidin Elution Buffer
(0.2% Biotin, 20 mM Tris pH 8.0, 400 mM NaCl, 10% glycerol, 0.1% DDM, 1 mM
EDTA, and 8.6 mM 2-Mercaptoethanol) to elute the SBP-tagged proteins through
affinity competition with Biotin. The eluate was recovered and stored at -80 ˚C.

Protein dialysis and Protein concentration assays
The recovered eluate (1 mL) was dialyzed to remove any traces of Biotin by using a
dialysis cassette of 10K MWCO and 4 L of TS Buffer (50 mM Tris/HCl pH 8.0, 150
mM NaCl, and 0.05% DDM). The cassette was suspended in the exchange buffer
and incubated for 4 hours at 4 ˚C with low stirring. A Bicinchoninic acid assay (BCA)
was performed to measure the concentration of the purified protein using a BCA
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protein assay kit (Pierce, 23227) and a plate reader set to measure absorbance at
562 nm. Albumin Standards (BSA) were used to build the standard curve and
calculate protein concentration of the dialyzed eluate. Because excess biotin in the
elution buffer can affect BCA assay results, an additional method was used to
measure protein concentration. The dialyzed eluate and a series of BSA standards
were analyzed by SDS-PAGE. The gel was stained with Coomassie blue for 1 hour
and de-stained for 2 hours before imaging. Protein concentration was estimated
through volumetric analysis of the Coomassie bands and linear regression was used
to build a standard curve with the BSA standard bands.

Nanodisc assembly
For nanodisc assembly, three types of zwitterionic lipids were tested, 1,2-dimyristoylsn-glycero-3-phosphocholine

(DMPC),

1-palmitoyl-2-oleoyl-glycero-3-

phosphocholine (POPC), and L-α-phosphatidylcholine (Egg PC). All of these were
purchased from Avanti Polar Lipids in chloroform solution. A specific volume of lipids
according to sample number and lipid fraction per sample was added to 13 x 100 mm
borosilicate glass test tubes and dried with Nitrogen gas. The tube was then placed
in a desiccator overnight to allow evaporation of chloroform traces. The lipids were
then hydrated in 10 mM Tris pH 8.0, 100 mM NaCl, 10% glycerol, and 20 mM DDM
to a final concentration of 10 mM and transferred to a 1.5 mL tube. The mixture was
sonicated in a water bath using 1 min pulses. The solution was then left on ice for 30
– 40 min until it appeared clear. Two types of membrane scaffold proteins were used,
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MSP1D1 (9 nm final nanodisc diameter) and MSP1E3D1 (12 nm final nanodisc
diameter). Both were purchased from Cube Biotech (MSP1D1- 26122, MSP1E3D1 –
26152). The membrane scaffold proteins were reconstructed by resuspending them
in ultrapure water and 5% glycerol to avoid aggregation.
A range of MSP:lipid ratio was tested for nanodisc assembly as described in the
Results. Ultimately, a 2:150-200 MSP:Lipid ratio was selected as optimal. We
attempted to have as close to 6 µM of purified full-length EGFR as possible for each
preparation. Phospholipid nanodiscs were assembled in the absence or presence of
EGFR. Nanodiscs containing EGFR dimers were assembled with EGFR pretreated
with EGF for 10 min at a 1:2 EGFR:EGF ratio prior to adding any other components.
The final volume of each sample was 300 µL. All samples were incubated on ice for 1
hour before detergent removal. After this period, BioBeads were used to induce
nanodisc assembly through detergent removal. Nanodiscs were incubated overnight
at 4 ˚C with gentle agitation. The samples were spun-down to collect the supernatant
containing the assembled nanodiscs and the BioBeads were discarded.
Ultracentrifugation was then carried on at 50k rpm for 20 min to remove any
aggregates. The supernatant was recovered, each sample was aliquoted and stored
at -80 ˚C.
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Native-PAGE analysis
Loaded nanodisc samples were loaded on a Native-PAGE to search for band
colocalization between target protein and MSP belt protein. 25 uL of nanodisc sample
were mixed with 2x native buffer (Bio-Rad 1610738) before loading in a 4-15%
precast gel (Bio-Rad 456-1084). Gel was run at 125 V for 1 hr at room temperature
and was transferred onto a nitrocellulose membrane. The membrane was blocked
with 3% BSA-TBS for 40 min and incubated overnight with primary antibodies (RON
β-E3 – Santa Cruz sc-74588; EGFR XP – Cell Signaling Technologies 4267L; His-tag
XP – Cell Signaling Technologies 12698S). Secondary fluorescent antibodies were
added and incubated for 1 hr at room temperature. The membrane was rinsed and
imaged on the Li-Cor Odyssey Fc (Li-Cor – 2800).

Size exclusion chromatography
Size exclusion chromatography of assembled samples was performed to separate
EGFR-loaded nanodics from empty nanodiscs using a GE Superdex 200 Increase
30/100 column (GE - 28990944). Molecular weight standards ranging from 29 kDa
to 700 kDa (Sigma-Aldrich - MWGF1000-1KT) were run prior to each batch of
samples. 100 µL per sample were run separately using 1.5 column volumes (CV) or
36 mL of TSG10 buffer (50 mM Tris/HCl pH 7.9, 100 mM NaCl, 10% glycerol) per run
and keeping the pressure in the column below 3 MPa. The column was washed with

21

2 CV of TSG10 in between each sample. Fractions of about 0.5 - 1 mL were collected
for each peak for further analysis.

His-Tag Pull-down
Nanodiscs were purified by His-tag affinity with Ni-NTA coated agarose beads using
the ProBond Purification Systems (Invitrogen - K85001) under Native conditions,
using the 5x Native Purification Buffer (250 mM NaH2PO4 pH 8.0, 2.5 M NaCl). As
controls, MSP1E3D1 alone and free EGFR were used, as well as empty nanodiscs.
ProBond slurry was resuspended and washed with ultrapure water and native binding
buffer (NBB - 50 mM NaH2PO4 pH 8.0, 0.5 M NaCl) before usage. 200 µL of each
nanodisc sample were used and NBB was added for a final volume of 300 µL per
sample. Each sample was added to 50 µL of ProBond slurry and left on rotation for 1
hr at 4 °C. The samples were spun down at low speed for 1 min, and the supernatant
was collected for SDS-page analysis. The resin was washed 4 times with 200 µL of
Native Wash Buffer (50 mM NaH2PO4 pH 8.0, 0.5 M NaCl, 20mM imidazole). Samples
were spun down at low speed between every wash and the supernatant was kept for
further analysis. The Ni-NTA agarose beads were denatured using 20 µL of 2x Laemli
reducing buffer and were boiled for 5 min.
An SDS-page was loaded with 20 µL of each sample’s denatured agarose beads,
along with supernatant and wash 1 and 4 per sample, including controls. SDS-page
was run for about 1 hr at 125 V. The gel was transferred to a nitrocellulose membrane
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and stained using REVERT total protein stain (Li-Cor - 926-11021) for 5 min. The
membrane was rinsed twice for 30 seconds using REVERT wash solution (Li-Cor 926-11022), and then washed 3 times using ultrapure water. The membrane was
then imaged on the Li-Cor Odyssey Fc (Li-Cor – 2800).

EGFR Immunoprecipitation
40 µL of empty nanodisc sample and purified EGFR as well as 20 µL of MSP1E3D1
were diluted separately in 300 µL of TSG10 to be used as controls for EGFR
immunoprecipitation. 10 µL of EGFR (clone R-1) conjugated agarose resin (Santa
Cruz - sc101 AC) were used for immunoprecipitation of each sample. Samples and
resin were added to separate 1.5 mL tubes. Samples were incubated overnight at 4
°C on rotation. Samples were spun down at 2000 xg for 5 minutes at room
temperature to remove the supernatant. Supernatant was stored for further SDSPAGE analysis. The resin was washed 8 times with 300 µL of TSG10. To denature
the resin, 25 µL of 2x Laemli reducing buffer were added and boiled for 5 minutes. 40
µL of the supernatant were denatured using 6x Laemli reducing buffer and boiled for
5 min. Samples were loaded on an SDS-PAGE. SDS-page was run for about 1 hr at
125 V. The gel was transferred to a nitrocellulose membrane and stained using
REVERT total protein stain (Li-Cor - 926-11021) for 5 min. The membrane was rinsed
twice for 30 seconds using REVERT wash solution (Li-Cor - 926-11022), and then
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washed 3 times using ultrapure water. The membrane was imaged on the Li-Cor
Odyssey Fc (Li-Cor – 2800).

Transmission Electron Microscopy imaging of EGFR and nanodiscs
Purified EGFR or EGF-treated EGFR were diluted 1:100 in PBS and stored on ice.
Purified empty or loaded nanodiscs were diluted 1:10 in PBS and stored on ice.
Carbon film (3-4 nm) 200 mesh nickel finder grids (Electron Microscopy Sciences EMS200-Ni) were glow discharged, and 5ul of sample were adsorbed to grids for 3
minutes. Grids were floated on water droplets twice for ten seconds, and then stained
twice with 0.75% uranyl formate (Electron Microscopy Sciences - 22400) for 10
seconds. The grids were wick dried with filter paper prior to storage. EGFR and
EGFR-loaded nanodiscs were labeled with colloidal gold, nanodiscs were adsorbed
to flow discharged grids, washed with PBS, and fixed for 5 minutes with 1%
paraformaldehyde (Electron Microscopy Sciences - 15700). The grids were floated
on 50mM glycine/PBS for 5 minutes and blocked with 0.1% BSA/PBS for 5 minutes.
Streptavidin or anti-his Nanogold (10 nm) was diluted 1:100 in 0.1% BSA/PBS and
samples were labeled for 15 minutes. Grids were floated on water droplets three
times for ten seconds and twice on droplets of 0.75% uranyl formate for ten seconds.
The grids were wick dried with filter paper prior to storage.
Images were acquired on a Hitachi 7700 Transmission Electron Microscope at a
magnification range of 50,000X-100,000X and drift correction.
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Single Nanodisc Imaging
Coverslip preparation. 25 mm coverslips were Piranha treated prior to their use to
remove organic residues from the glass surface. Coverslips were allowed to dry
before drawing 2 x 2 array on each one using a hydrophobic PAP pen. Once the array
was drawn, the coverslips were dried and placed in a humidified container. BiotinPEG and mPEG were diluted in 10mM solution of sodium bicarbonate buffer pH 8.5
at 6.4 mg/mL and 250 mg/mL, respectively. The solution was spun down at 10,000
xg for 1 min at room temperature to remove bubbles. The solution was applied to
each array and all coverslips were left incubating in a humidified container for 3 to 4
hrs at room temperature while protected from the light. Coverslips were washed
repeatedly with ultrapure water and dried with nitrogen. Coverslips were stored at
-20 °C in a sealed parafilm-lined container and were used within a week.

Coverslip surface functionalization. Surfaces were functionalized in a manner similar
to that described in Salazar-Cavazos et. al., 2018. Arrays on 25 mm coverslips were
equilibrated to room temperature and placed on a TC100 plate lined with parafilm.
Each region of the array was treated with a 10 mg/mL NaBH4/PBS solution for 4 min
at room temperature and washed 3 times with PBS. Each array was treated with 0.2
mg/mL of NeutrAvidin (Thermo Scientific – 31000) in T50 Buffer (10 mM Tris pH 8.0,
50 mM NaCl). Then, each region was treated with either biotinyated α-EGFR (Leinco
- E101) or biotinylated α-His Tag (Thermo Fisher Scientific MA1-21315-BTIN) for 10
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min at room temperature. Each coverslip was washed 3 times with T50-BSA (10 mM
Tris pH 8.0, 50 mM NaCl, 0.1 mg/mL BSA). EGFR-embedded nanodisc samples were
diluted 1:250 in PBS. Free EGFR (1:1000 in PBS) and empty nanodiscs (1:250) were
used as controls. All arrays were placed on ice, samples were then added to their
respective area on the array and left incubating for 10 min. The arrays were washed
4 times with T50-BSA.

Nanodisc Labelling. DiD (ThermoFisher Scientific - V22887) was used to label the
nanodiscs and was diluted 1:2000 in T50-BSA, along with α-EGFR AF555 conjugate
(Cell Signaling – 5108) at a 1:50 dilution to label EGFR. The lipid dye and the
fluorescent antibody were added to the array and incubated for 1 hr on ice. The array
was then washed 6 times with T50-BSA and then twice with cold PBS before imaging.
A second set of coverslips with 2x2 arrays were treated with Neutravidin only. Loaded
nanodiscs were pulled down by using affinity precipitation between Avidin and SBPtagged EGFR. Nanodisc samples were incubated on Neutravidin-treated coverslips
for 10 min. The arrays were washed with T50-BSA 4 times and labelled with α-EGFR
R-1 clone AF647 (Santa Cruz - sc101) and α-His XP AF488 (Cell Signaling
Technology - 14930S) conjugates at a 1:50 dilution to label EGFR and His-tagged
MSP1E3D1, respectively. Each area of the array was washed again as described
above.
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Single Nanodisc Imaging. The array was equilibrated to room temperature for 5 min
prior to imaging. Each area on the 2x2 array on the 25 mm coverslip was imaged on
a custom-built system from an inverted microscope (IX71, Olympus America Inc)
(Schwartz et al., 2017; Valley et al., 2015). 642 and 561 lasers were used at a laser
power of 5 mW and 1 mW, respectively. These lasers were coupled into a multi-mode
fiber (P1-488PM-FC-2, Thorlabs) and focused onto the back focal plane of the
objective lens with a 1.45 NA (UAPON 150XOTIRF, Olympus America Inc.) (Schwartz
et al., 2017; Valley et al., 2015). Sample illumination and emission were achieved
using a quad-band dichroic and emission filter set (LF405/488/561/635-A; Semrock).
A band-pass filter (685/45, Brightline) was used for emission light filtering. Emission
was collected on an electron-multiplying charge-coupled device (EM CCD) camera
(iXon 897 – Andor Technologies. Images were 256 x 256 pixels per channel, with
each pixel being 0.1067 µm. The emission path includes a quad band optical filter
(Photometrics, QV2-SQ) with 4 filter sets (600/37, 525/45, 685/40, 445/45,
Brightline) and the EM CCD camera mentioned above (Schwartz et al., 2017; Valley
et al., 2015).
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CHAPTER 3: RESULTS
3.1. Protein purification and nanodisc assembly
3.1.1. Protein purification method
The first step required for structural studies of EGFR and RON interactions was to
produce and purify receptors. To maintain receptor functionality and insure proper
expression and conformation, full-length EGFR and RON plasmids were transfected
into the human embryonic kidney cell line, HEK293. Stable cell lines expressing EGFR
or RON were selected using G418. For purification, both plasmids expressed a
Streptavidin-Binding Peptide tag (SBP-tag) at the C-terminus of the receptor. The
SBP-tag is a 38-amino acid sequence that can bind to streptavidin but has a lower
affinity for streptavidin than biotin’s affinity for streptavidin. SBP-tagged proteins can
be purified using streptavidin agarose resin and eluted from the beads by adding
biotin. This purification method has been used previously to purify EGFR protein for
nanodisc assembly (Mi et al., 2008). Streptavidin purification is ideal for structural
studies on full-length receptors as it preserves protein functionality and structure by
using gentle elution conditions, and thus avoiding protease digestion. The streptavidin
protocol also uses freeze-thaw cycles for cell lysis. Freeze-thawing is a cell disruption
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method that allows lysis of the cells
without sonication or the addition of
harsh detergents, which could denature
the proteins.
Purification from HEK293 adherent cells
resulted in low protein yield that was not
optimal for nanodisc incorporation.
Previous work suggested 26.5 µg of
target protein was needed for each
nanodisc preparation (Mi et al., 2008).
About six T175 flasks totaling in 6x108
HEK293 cells yielded about 6 µg of
target protein after elution. This eluate
Figure 4. A. Transient transfection of
recombinant protein in Expi293F cells. Purified
protein from Expi293F cells transiently
transfected with full-length RON, RON
fragments (Kinase domain (KD), and
Extracellular domain (ECD)), and full-length
EGFR. Lane 1 shows purified full-length (FL)
RON from HEK293 cells after CHX treatment,
while lane 2 shows the same recombinant
protein in Expi293F cells. The top band (white
arrow) indicates pro-RON. B. Confocal imaging
of Expi293F cells transfected with RON FL show
unprocessed RON sequestered in the
Endoplasmic Reticulum instead of localized on
the cell membrane. RON detected using the
mNeonGreen tag (mNG) (green), and the RON
β E3 antibody (red)

with a concentration of 30 µg/µL
needed to be concentrated using
centrifugal

concentrators,

which

caused protein losses due to nonspecific binding to the concentrator’s
membrane. After concentration, the
entire eluate was used for a single

nanodisc preparation, making it difficult to run any additional controls. Therefore, a
modified high-density suspension cell line (Expi293F, Gibco), a derivative of HEK293,
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was transiently transfected with full-length RON, RON Kinase domain (RON-KD),
RON extracellular domain (RON-ECD), as well as full-length EGFR. Figure 4A shows
the total lysates of full-length receptors and protein fragments. The Expi293F cell line
has been optimized for high protein production. With this system, we obtained a
higher yield of around 0.25 – 0.3 mg, while still culturing in human cells. Initially, this
cell line was not fully processing the full-length RON receptor. This can be observed
in the blot (Figure 4A), and in confocal imaging of the cells where RON appears to be
in the Endoplasmic Reticulum rather than localizing to the plasma membrane (Figure
4B).

Figure 5. A. CHX treatment on HEK293 and Expi293F cells for RON processing. Total lysate of HEK293
adherent cells with no treatment, and after 2, 4, and 6 hrs of CHX treatment. Untreated cells have a high
content of pro-RON (top band), while treated cells have a larger ratio of mature RON (lower band). The
graph bellow shows that CHX treatment reduces the Pro-RON to RON ratio from 1:2 to approximately
1:10. B. CHX treatment on Expi293F cells expressing RON FL. Untreated cells have an almost 1:1 ratio
of pro-RON (top band) to RON (bottom band). After a 4 hr CHX treatment, total lysate shows a decrease
on pro-RON to a 1:4 ratio.
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The RON gene encodes a 190 kDa protein (pro-RON) that is intracellularly cleaved
and re-arranged into a two-chain heterodimeric receptor with a 40 kDa α-chain, and
a 150 kDa β-chain held together by disulfide bonds (Peace, 2003). These two forms
can be distinguished on the western blot in Figure 4A, lane 1, which corresponds to
a purified sample of RON expressed in HEK293 cells. The α-chain is entirely
extracellular, while the β-chain comprises an extracellular domain, a single-pass
transmembrane domain, and a larger cytoplasmic domain where the tyrosine kinase
resides. For RON cleavage and re-arrangement to occur, the single chain Pro-RON
undergoes proteolytic cleavage at a specific site (K305 – R – R – R – R309) that breaks
the peptide bonds between amino acids and generates mature RON. Without this
conversion, RON cannot be activated.
Given this characteristic processing of RON, cells transfected with full length RON
plasmid were cultured and treated with Cycloheximide (CHX), a protein synthesis
inhibitor that prevents translational elongation, thus inhibiting pro-RON production.
The majority of RON receptors will mature during the incubation with CHX, increasing
the ratio of processed to pro-RON forms in the preparation (Figure 5A). After CHX
treatment, total lysates were analyzed by western blotting for the SBP-tag. HEK293
cells treated with CHX saw a reduction in the Pro-RON to RON ratio from 1:2 without
treatment to 1:10 with treatment according to blot quantification (Figure 5A, graph).
After optimization of growth conditions, CHX treatment was also tested on the
Expi293F cells. The total lysate after treatment was analyzed by western blotting for
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the SBP-tag (Figure 5B). CHX treatment for four hours also increased the fraction of
mature RON in the Expi293F cells from a 1:1 to 1:4 pro-RON:RON ratio.
For purification of full-length receptors from the Expi293 lysates, we followed the
general protocol for purification of SBP-tag proteins and optimized it to better fit our
system.
For efficient binding and elution, we
found that dividing the total lysate
into 5 to 6 1 mL batches and adding
100

µL

of

streptavidin

resin

increased purification efficiency.
This

small

batch

processing

decreased protein losses. Large
batch processing may be less
efficient due to improper contact of
the resin with the elution buffer or
Figure 6. Streptavidin affinity-based purification in smallbatch mode shows the amount of protein in each sample in
relation to the total protein in the initial lysate. The
supernatant (2nd lane) shows a very small amount of EGFR
unbound to the resin. The first elution (3rd lane) shows a
protein rich sample, while the second elution (4th lane)
indicates that nearly all protein is eluted in the first elution.
1-2% protein remains stuck to the resin (5th lane) despite
the two elutions. Protein recovery is shown in the graph
bellow

resin drying out in the larger 15 mL
tubes. To increase protein elution,
we doubled the concentration of
biotin present in the elution buffer

by using 0.2% biotin instead of the suggested 0.1%. This increase in biotin
concentration should not have adverse effects on protein functionality or structure.
The purification process of EGFR using the small-batch process is shown on the blot
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in Figure 6. Binding of the receptor to the beads is seen as a decrease in receptor
levels in the supernatant. Purified protein in the eluate is shown on the right. Unbound
protein remaining in the supernatant and residual protein bound to the resin was
quantified based on the volume of the eluate to determine protein losses during the
purification process. Approximately 9-10% of the protein did not bind to the resin and
was lost in the supernatant, while 1-2% of target protein was lost by remaining bound
to the streptavidin resin (Figure 6).
The purification process was initially tested using two detergents, n-dodecyl-β-Dmaltoside (DDM) and Triton X-100. No difference in the purification process was
observed between the two detergents. No difference in the purification process was
observed between the two detergents. Therefore, given EGFR’s solubility in DDM and
the detergent’s ability to preserve the receptor’s functionality (Mi et al., 2008), DDM
was used rather than Triton X-100 or the standard NP40.
We found that the biotin in the elution buffer affects protein quantification by standard
BCA methods. Even a 1:100 dilution of the biotin buffer alone caused a rapid color
change in the BCA assay. Concentration and buffer exchange of the eluate to remove
excess biotin was attempted using centrifugal concentrators with a low molecular
weight cut-off (MWCO). This resulted in protein losses due to non-specific binding to
the concentrator’s membrane. Therefore, we developed an alternative quantification
method where the protein concentration of the eluate was estimated using BSA
standards on an SDS-PAGE gel. The gel was stained with Coomassie Blue, and the
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BSA

bands

were

quantified to create a
standard

curve.

The

concentration of purified
EGFR
receptors

and
was

RON
then

estimated using the BSA
standard curve as shown
in Figure 7. We obtained
Figure 7. A. BSA standard SDS-PAGE for protein quantification. BSA
standards were run in an SDS-PAGE along with full-length EGFR purified
from HEK293 cells and Expi293F cells. The gel was stained with
Coomassie Blue. B. A standard curve was built using these standards
to calculate the concentration of purified EGFR.

around 200– 300 µg of
target

protein

from

Expi293F cells (Figure 7, lane 8 – Expi293F Eluate 1). As mentioned above, HEK293
cells yielded approximately 20-25 µg during the first elution, needing further
concentration for nanodisc assembly (Figure 7, lane 7– HEK293 eluate 1). Based on
previous work (Mi, et al., 2008) we used 75 µL of the first elution from Expi293F cells
for a final concentration of 1 µM or 13.5 µg of EGFR as suggested.

3.1.2. EGFR dimers and RON incorporation in nanodiscs
Previous work in our group tried to incorporate EGFR and RON into pre-formed
nanodiscs (Cube Biotech). Although this worked for receptor fragments, the fulllength receptors were never incorporated based on native gels. We concluded that
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the bulky domains on either side of the transmembrane domain of these receptors
likely prevents them from spontaneously incorporating into pre-formed nanodiscs.
The alternative method is to assemble nanodiscs from their components around the
protein to be embedded. For assembly, we started with purified protein in detergent
micelles combined with MSP belt protein and phospholipids. Nanodisc assembly is
initiated by removing the detergent. The ratio of belt protein, lipids, and receptor is
critical for proper nanodisc formation. Here we optimized nanodisc assembly by
testing ratios of MSP:Lipid:membrane protein, as well as testing two sizes of nanodisc
and different phospholipids. Different belt proteins can form nanodiscs with specific
diameters, and the choice of nanodisc size should be based on the size of the
embedded protein of interest. EGFR is a membrane protein with an extracellular
domain and a cytoplasmic kinase domain, both of which are of considerable size.
These two domains are linked by a single-pass transmembrane domain that, upon
nanodisc assembly will be embedded within the lipid membrane of the nanodisc.
Taking these structural characteristics of our target protein into account, nanodiscs
were assembled using two Membrane Scaffold Proteins (MSPs) that produce
nanodiscs of two different diameters.

Phospholipids with different carbon-chain

length were also tested to achieve proper embedding of the transmembrane domain
based on nanodisc thickness. Target proteins (Full-length EGFR or RON) were added
to the nanodisc mixture simultaneously with the MSP belt protein and hydrated
phospholipids. Detergent was removed using non-polar polystyrene adsorbent
beads.
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3.1.3. MSP1D1 and DMPC nanodiscs
Our first experiments were based on previous literature of EGFR incorporation in
nanodiscs (Mi et al., 2008). We used a mixture of the standard-sized belt protein
MSP1D1 and DMPC at a 2:100 ratio. DMPC is a saturated 14-carbon chain synthetic
phospholipid that is regularly used in liposomes and lipid bilayers. MSP1D1 is a belt
protein that yields nanodiscs of 9.6 nm in diameter. To detect incorporation of fulllength receptor into the nanodiscs, we analyzed the nanodisc samples by nativePAGE. Nanodisc preparations were loaded and run on a native-PAGE without
denaturing. The native gel was stained with Coomassie blue or transferred onto a
nitrocellulose membrane and labelled with primary antibodies against His-tag to
detect MSP1D1, and against RON or EGFR to detect the receptor. Fluorescent
secondary antibodies were used to detect both MSP1D1 and the receptor labeling on
the same gel. The native-PAGE separates the nanodiscs from the unincorporated
target proteins and the protein-loaded nanodiscs from the empty based on their mass
to charge ratio. If the receptor was incorporated into nanodiscs, we expected to see
colocalization of MSP1D1 and the target protein (EGFR or RON) in a higher molecular
weight band (Figure 8A). Empty nanodiscs were run as a control. Based on these
experiments, we found colocalization between a higher nanodisc band and the band
representing the target protein, indicating potentially loaded nanodiscs. Figure 8A
shows colocalization of the EGFR and nanodisc band (yellow) which suggests EGFRloaded nanodiscs. However, the incorporation is not efficient when compared to the
empty nanodisc band (green).
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3.1.4. Optimization of nanodisc size and lipid composition
One of the main purposes
of this study is to assemble
nanodiscs with EGFR and
RON

heterodimers.

Nanodiscs

of

diameter

may

a

incorporate

better
these

heterodimers.
Figure 8. Native western blot of EGFR-incorporated MSP1D1 and
MSP1E3D1 nanodiscs. A. Native-PAGE of MSP1D1-DMPC assembled
nanodiscs. MSP1D1 (1st lane - green) is run, along with empty
nanodiscs (2nd lane - green), as a control to compare changes triggered
by assembly. Loaded nanodiscs can be seen in lane 3 and expected
colocalization (yellow) between MSP1D1 (green) and EGFR (red) can be
seen. Single color blots are shown below. B. Comparison between
MSP1D1 and MSP1E3D1-assembled nanodiscs on a Native western
blot. MSP1E3D1 (2nd lane – green) is a longer protein based on
MSP1D1 (1st lane – green). In the native gel, the difference in their mass
and charge can be observed. MSP1D1 nanodiscs (lane 3 and 4 – green)
present a band (arrow) that runs at a similar height as EGFR (4th lane –
red), causing possible false positive colocalization (4th lane – yellow).
MSP1E3D1 nanodiscs (lane 5 and 6) do not present a similar band,
preventing false positives on native western blots. Single color blots are
shown below.

larger

Therefore,

we tested a larger size of
MSP belt protein to form
nanodiscs with a larger
diameter. MSP1E3D1, an
extended

version

of

MSP1D1 with helices 4, 5,
and 6 repeated (Bayburt

and Sligar, 2010), was used for these experiments. MSP1E3D1 nanodiscs show a
single empty nanodisc band, unlike the MSP1D1 empty nanodiscs preparations which
would sometimes show a secondary higher band. Because this band was similar to
the size of the incorporated nanodisc, overlap could result in a false positive
colocalization (Figure 8B).
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Next, we optimized the phospholipid composition of the nanodiscs. Based on
molecular dynamics studies by collaborator César López Bautista (Los Alamos
National Laboratory), phospholipids with short carbon-chains, such as DMPC, may
not be ideal for transmembrane receptor embedding. Lipids with longer carbonchains

may

provide

optimal embedding of the
transmembrane

domain

based on nanodisc height
and
Figure 9. Phospholipid species and ratio analysis in MSP1E3D1
assembled nanodiscs. MSP1E3D1 nanodiscs were assembled with
different ratios of phospholipids to find optimal conditions. Nanodiscs
containing 150 to 200 phospholipid molecules were successfully
assembled with no major differences visible in Native-PAGE. Nanodiscs
with 600 lipid molecules tended to form higher molecular weight
aggregates.

transmembrane

domain length. We tested
two

phospholipid

preparations, EggPC and
POPC. POPC is a 16

carbon-chain saturated phospholipid. EggPC is a natural lipid mixture of mainly
POPC, but with low levels of cholesterol and sphingomyelin, providing a more nativelike lipid bilayer. Several MSP to phospholipid ratios (2:150, 2:200, and 2:600) were
tested for nanodisc assembly. Upon nanodisc assembly the higher molecular weight
band shown by MSP1D1 was not present in MSP1E3D1 nanodisc assemblies (Figure
8B). Assembled empty nanodiscs were seen with both POPC and EggPC. Since a
natural lipid mixture such as EggPC would act similar to a native-like membrane, we
chose to use EggPC to embed our membrane proteins. The optimal ratio for assembly
was 2:150-200 MSP1E3D1 molecules to EggPC phospholipid molecules. This can be

38

seen in Figure 9, based on the
tightness of

the

assembled

nanodisc bands on the nativePAGE for 2:150-200 (Lanes 2 –
6) belt protein to lipid ratios. A
sample with a 2:600 MSP1E3D1
to EggPC or POPC ratio was
prepared as a negative control
for nanodisc assembly. Bao et
Figure 10. Native electrophoresis and fluorescent western
blotting of MSP1E3D1-EggPC assembled nanodiscs (+/-) EGFR
and EGFR dimers. MSP1E3D1-EggPC nanodiscs were
assembled at 2:100 and 2:150 MSP belt protein to Lipid ratio.
Purified EGFR from Expi293F cells was added to the nanodisc
mixture. EGFR was stimulated with a 2x of EGF for 10 min to
form dimers prior to adding to the mixture. In this western blot,
colocalization is visible in 2:100 nanodiscs with EGFR dimers, as
well as 2:150 nanodiscs with single EGFR protein. This shows
that dimer incorporation is dependent on lipid molecules per
nanodisc.

al., 2012 suggests that lipid-rich
assemblies such as these tend
to form aggregates. Based on
the native-PAGE in Figure 9
(lanes 6 and 7), we concluded

that at this MSP to lipid ratio, the size of the nanoparticles produced is not
homogeneous.
The next step was to assemble nanodiscs with embedded EGFR. Approximately 1 µM
of EGFR was used per sample preparation. To encourage the formation of EGFR
dimers, 2 µM of EGF was added to the purified EGFR before adding the protein to the
nanodisc mixture. Nanodiscs were assembled overnight by removing the detergent.
Figure 10 shows our results. Nanodisc assembly using a 2:100 MSP to lipid ratio
shows overlapping of EGFR and the assembled nanodiscs bands, showing embedded
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nanodiscs with EGF-bound EGFR. The sample with a 2:150 MSP to lipid ratio also
shows overlapping bands for untreated EGFR and assembled nanodiscs. This means
that there is a fraction of nanodiscs that have unliganded EGFR monomers embedded
in them. A sample with fewer lipid molecules
per

nanodisc

potentially

provides

the

necessary space to embed dimeric EGFR. This
phenomenon needs to be further explored.
EGFR incorporation into our nanodiscs was
displaying low efficiencies and protein loses.
For further optimization, we examined whether
the protein is being lost during nanodisc
Figure 11. Fluorescent western blot of
denatured BioBeads after overnight detergent
removal for nanodisc assembly. MSP1E3D1
was used as a control and was loaded
according to the amount used for nanodisc
assembly. An EGFR only control was added to
the BioBeads for overnight detergent removal,
as well as an empty nanodisc and a loaded
nanodisc samples. The BioBeads were
denatured by boiling using reducing buffer to
remove any protein bound. As seen on Lane 3
and 4, there is some minor nanodisc residue,
however EGFR residue is almost undetectable
on lane 4. The EGFR only control on lane 2
also shows a very small amount of residue.
This experiment shows that protein losses are
not likely due to aggregation and attachment
to the BioBeads during assembly.

formation. Nanodisc assembly is triggered by
detergent removal. Detergent can be removed
using dialysis or adsorption using macroporous
polymeric beads or BioBeads. It has been
suggested (Franz Hagn et al., 2018) that the
membrane protein of interest may bind to the
Biobeads yielding a low number of loaded
nanodiscs. To test if the yield of EGFR-

embedded nanodiscs (Figure 10) was low due to the target protein aggregating and
binding to the BioBeads, we added denaturing sample buffer to the beads to remove
any residual proteins non-specifically bound to the BioBeads. These samples were
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analyzed by fluorescent western blotting for His-tag and EGFR to detect residual
MSP1E3D1 and target protein, respectively (Figure 11). Some nanodisc residue
remains on the beads after overnight detergent removal. However, the BioBeads
contained very little EGFR bound as shown by the nearly undetectable EGFR band
(Lane 4). An EGFR only control was added to the BioBeads and was incubated
overnight with rotation. As seen on Figure 11 – lane 2, this control also presented a
very faint band of EGFR bound to the beads. We concluded that protein losses were
not likely due to aggregation and binding to the beads.

3.2. Nanodisc protein incorporation detection methods
Because native electrophoresis and western blotting analysis was sometimes difficult
to interpret, we wanted to establish an alternative method for determining protein
incorporation into nanodiscs that would allow us to distinguish loaded nanodiscs from
empty nanodiscs. Detection methods tested include size exclusion chromatography,
imaging techniques, and biochemical assays.
3.2.1. Size exclusion chromatography
Previous nanodisc studies have used size exclusion chromatography to purify loaded
nanodiscs from empty nanodiscs or free receptor (Mi et al., 2008; Bayburt and Sligar,
2010; Hagn et al., 2018). Therefore, we tried this detection method on the
MSP1E3D1 - EggPC samples using a small-scale agarose-based size exclusion
chromatography column (Superdex 200 Increase 10/300). We compared our
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nanodisc assembly samples to a series of gel filtration calibration standards, ranging
from 29 kDa to 700 kDa (Figure 12). These standards were used to approximate the
molecular weight of our eluted nanodiscs, and controls based on their elution time.
Given this information, our empty nanodiscs assembled with MSP1E3D1 and EggPC
have an approximate molecular weight of 150 kDa, which is within what is expected
according to the literature (Bayburt and Sligar, 2010). Our loaded nanodiscs eluted
at around 19 min. According to our standards the loaded nanodiscs would have a
molecular weight of around 400 kDa. This matches our approximation based on the
receptor (175kDa) and the nanodisc (150kDa) molecular weights added together.

Figure 12. Size exclusion standards ranging from 669 kDa to 29 kDa, and Blue Dextran at 2000 kDa. These
standards were run on the same size exclusion column before any nanodisc samples. The elution time of these
standards was used to approximate the molecular weight of the eluted nanodiscs and controls
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A

series

controls

of
were

run

separately

on

the

size

exclusion
Figure
13.
Nanodisc
controls.
MSP1E3D1 and Biotin buffer were run
separately as controls to observe their
time of elution and compare to nanodisc
samples, both of these peaks are eluted
at very similar the nanodisc samples.
Empty
nanodisc
at
2:600
MSP1E3D1:Lipid ratio was run as an
“aggregate” control based on the results
obtained on the native-PAGE (Figure 9).
This control shows a variability in sizes
that
makes
the
sample
nonhomogeneous.

column

to

observe

their

peaks

and

elution

time

(Figure

13).

MSP1E3D1 has

a representative peak at 29-30 min. This peak appears at the same time on empty
and loaded nanodisc samples, indicating that some free MSP belt protein is in
solution. The 4mM biotin buffer was also run to confirm that the late peak at 40-41
min was due to the buffer. A third control of empty nanodiscs with an MSP to lipid
ratio of 2:600 was run as “aggregates” based on the results obtained by
electrophoresis in Figure 9. These empty nanodiscs with an excess amount of lipid
molecules form lipid-rich molecules that show a variability in sizes. In this nanodisc
“aggregate” control, the spectrum obtained shows a very broad distribution in sizes.
Loaded nanodiscs have a distinct peak at 19.6 minutes that corresponds to a
molecular weight of 400 kDa (Figure 14A). Based on the calculated molecular weight
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of the nanodisc and the
receptor, this peak is likely
the loaded nanodisc. This
peak is not visible in empty
nanodisc samples (Figure
14B). The peak around 30
min or 32 kDa corresponds
to the belt protein, based on
the MSP1E3D1 control seen
in Figure 12. The peak at
around 24 min is likely the
empty nanodisc since it is
present in both assemblies
(Figure 14B). During elution,
Figure 14. Size exclusion chromatography of empty and loaded
nanodiscs. A. Loaded nanodiscs show around 19.6 – 20 min. B.
Empty nanodisc spectrum shows no peak at 19 – 20 min. Empty
nanodiscs show at 24 min, and aggregates at 13 min. MSP1E3D1
shows in both spectra at around 29 min.

500

µL

collected.

fractions

were

Fractions

associated with each visible peak were analyzed by SDS-PAGE and western blotting.
Unfortunately, no bands were visible, suggesting that the fractions collected were too
dilute to detect. Further concentration using low MWCO centrifugal concentrators did
not improve the detection.
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3.2.2. Affinity precipitation: His-tag PullDown
According

to

the

literature, isolation of
loaded nanodiscs can
be performed through
affinity precipitation by
using a specific tag on
the embedded protein
(Bayburt and Sligar,
Figure 15 A. REVERT total protein staining of blotted samples from His-tag
affinity precipitation using Ni-NTA resin. A. His-tagged MSP1E3D1 with and
without His-tag pulldown (Lane 1 and 2). Comparison between no treatment
(lane 3) and His-tag pulldown (lane 4) of empty nanodiscs. Loaded
nanodiscs with FL-EGFR showing presence of EGFR on pulldown samples
(lane 6). B. EGFR His-tag pulldown indicating EGFR non-specific binding to
Ni-NTA resin.

2010; Hagn et al.,
2018). In our case, we
used

affinity

precipitation of the His-tag coupled with SDS-PAGE as a detection method of target
protein embedding into nanodiscs. Ni-NTA agarose resin was used to pull-down
nanodiscs with the 6x His-tagged MSP1E3D1. A series of controls were used,
including empty nanodiscs as a positive control for pull-down, and purified EGFR as
a negative control. Complexes bound to the Ni-NTA resin were denatured by boiling
and analyzed by SDS-PAGE to identify the proteins that were captured on the resin.
The gel membrane was stained with REVERT total Protein Stain (Licor - 926-11010)
to detect the proteins (Figure 15).
A visible band at 150 kDa showed that EGFR was present in the assembled
MSP1E3D1 – EggPC nanodisc pull-downs. A negative control of EGFR only at a
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similar concentration as the one used for nanodisc preparation was also pulled-down
using Ni-NTA resin. This control showed that EGFR itself was binding to the Ni-NTA
resin (Figure 15A), making it impossible to distinguish between EGFR embedded in
nanodiscs and EGFR bound non-specifically to the Ni-NTA resin. This experiment was
repeated using an EGFR only control, with similar results to those observed previously
(Figure 15B). Pull-down conditions will need to be optimized to limit non-specific
binding of EGFR perhaps through further stringent washes. Alternatively, cobalt
beads can also bind His-tagged proteins with fewer risk of non-specific binding.

3.2.3. EGFR Immunoprecipitation
Given the non-specific binding of EGFR to the Ni-NTA resin, we attempted pull-down
of EGFR-loaded nanodiscs by immunoprecipitating EGFR. To do this, we tested a
series of controls on agarose resin conjugated with α-EGFR (clone R-1) antibody. The
controls included free EGFR, free MSP1E3D1, and empty nanodiscs. These controls
were tested before trying any loaded nanodiscs to observe if any MSP1E3D1 or
assembled nanodiscs would non-specifically bind to the α-EGFR conjugated resin.
The bound complexes were was denatured by boiling and analyzed by SDS-PAGE
and REVERT total protein staining. The results can be seen in Figure 16. The first two
lanes show MSP1E3D1 and EGFR as non-IP controls. The following 6 lanes show the
IP for each control and unbound protein or complex on the supernatant after overnight
binding. In the EGFR control, we see EGFR binding to the resin. The MSP1E3D1
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control shows low non-specific binding to the α-EGFR conjugated resin with most of
the belt protein remaining
in the supernatant after
binding. Despite these
favorable

results,

the

empty nanodisc control
shows a strong band for
MSP1E3D1,

indicating

that the empty nanodisc
is bound to the resin.
There could be some
interactions between the
conjugated resin and the

Figure 16. REVERT total protein staining of EGFR immunoprecipitation
using agarose beads conjugated with α-EGFR (clone R-1). During this
IP, we tested several controls before attempting nanodisc IP via
embedded EGFR. The resin was denatured by boiling. The supernatant
(S/N) or unbound sample was also loaded on the gel to test for losses or
unspecific binding. Lane 1 and 2 show MSP1E3D1 and EGFR that did
not undergo IP. Lane 3 and 4 show IP of EGFR FL. Lane 4 shows
MSP1E3D1 unspecific binding to α-EGFR conjugated beads. Lane 6
shows unspecific binding of assembled empty nanodiscs to the resin as
well.

lipids that form the nanodiscs. Given these results, we decided that pull-down of
EGFR-embedded nanodiscs with this method would not be feasible since nonspecifically bound nanodiscs could affect our ability to distinguish between loaded
and empty nanodiscs
.
3.2.4. Transmission Electron Microscopy
Given their homogeneity in size, the use of nanodiscs for Electron Microscopy allows
us to acquire higher resolution structures of membrane proteins. Nanodiscs also
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prevent aggregation of target proteins while preserving their structure and function.
These characteristics make nanodiscs a great tool for structural studies as they
provide greater uniformity for membrane protein imaging than liposomes or micelles.
In this work, we used EM and negative staining to observe structural and size
differences between loaded and empty nanodisc samples to confirm EGFR
embedding. As controls, we used EGFR treated with EGF to promote dimer formation,
as well as empty nanodisc samples with excess lipids that are known to form
aggregates and complexes of varying sizes. The grids were negatively stained using
uranyl formate and SBP-tagged EGFR was labelled with streptavidin nanogold. The
acquired images were analyzed to obtain average size of the nanodiscs, as well as
height and length of EGFR receptors.
Figure 17 shows EM micrographs of the negatively stained samples. EGFR treated
with EGF in a number of different orientations can be seen in Figure 17A. These
negative stain images show two densities of globular appearance that could be the
extracellular and kinase domains of EGFR (Figure 17A, indent). These two densities
are connected by a single-pass transmembrane domain that has a smaller density
and is perpendicular to the ECD. Lipid-rich empty nanodisc samples with an MSP to
lipid ratio of 2:600 were imaged using EM as a control for aggregates (Figure 17B).
This sample shows larger aggregates with a wide distribution in size and a general
circular appearance. The appearance of this sample matches our results obtained
through size-exclusion chromatography and native-PAGE, where these samples
appear to have complexes that are non-homogeneous in size. Figure 17C
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corresponds to empty nanodiscs with an MSP to EggPC ratio of 2:150. This sample
has a homogeneous nanodisc size with a distinctive circular appearance and hollow
center, similar to those reported by Raschle et al., 2016. These images are in
accordance with the results obtained through native-PAGE, western blotting, and size
exclusion chromatography, where nanodiscs of a 2:150 – 200 MSP belt protein to
lipid ratio appear to have a defined size that varies within a certain margin. This can
be seen in the distinct nanodisc elution peak in size-exclusion spectra, and in the
defined bands for nanodisc assembly in the native-PAGE and western blotting. Finally,
loaded nanodiscs with EGF-treated EGFR were imaged using negative staining and
EM (Figure 17D). This sample has nanodiscs with an MSP belt protein to lipid ratio of
2:150 and contains empty nanodiscs as well as loaded nanodiscs with dimeric and
monomeric EGFR. This diversity in the sample can be observed in the variability of
size and different structures that may correspond to protein orientation in nanodiscs
embedded with dimeric or monomeric EGFR as well as free EGFR protein. For this
sample, SBP-tagged EGFR was labelled using streptavidin nanogold. The inset on
Figure 17D shows EGFR labelled with streptavidin gold embedded in a nanodisc with
a distinct “circular” shape representing the nanodisc, and two separate densities on
each side for the ECD and KD of embedded EGFR. A selection of potentially loaded
nanodiscs is displayed in Figure 17E. These complexes show a number of different
shapes, which suggests a variability in structures associated with the number of
receptors in the nanodisc, protein orientation, and nanodisc orientation.
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Images from TEM were analyzed based on their width and length of several structures
identified. These measurements were averaged (Figure 18). The lipid-rich empty
nanodiscs (Figure 18A), had an average of all measurements of 14.2 nm (n=32),
which is larger than the expected size for MSP1E3D1 assembled nanodiscs. The
measurements for these lipid-rich nanoparticles are shown in Table 1. The histogram
corresponding to these aggregates (Figure 18A) shows a wide range of nanodisc
sizes, which is in accordance to previous size-exclusion and native-PAGE results, as
well as what can be observed in the EM images. In comparison to these lipid-rich
particles, empty nanodiscs of an MSP to lipid ratio of 2:150 (Figure 18B) display a
defined size and less variability based on the histogram. These nanodisc display an
average of 12.4 nm through all measurements (n=31). This corresponds well with the
average diameter of 12.1 nm for nanodiscs formed with MSP1E3D1 belt protein as
previously described (Denisov et al., 2004). Width and length averages for this sample
can be seen in Table 1. EGFR dimer samples (no nanodisc) were analyzed and
compared to published data from Mi et al., 2011. Based on the literature, the average
measurements for EGFR dimers are 10 nm wide and 20 nm long. Our measurements
indicate an average width of 10.5 nm and length of 20.9 nm for structures in the EGFR
dimer samples (Figure 18C). The histogram for these measurements shows a bimodal
distribution, where the first normal distribution corresponds to width and the second
to length. EGFR loaded nanodiscs on Figure 18D display a broad distribution. The
average length for this sample is 19.8 nm (n=48), similar to the average length of
EGFR dimers. The average width for the loaded nanodiscs is 13.9 nm, a measurement
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that is larger than that of empty nanodiscs. In short, the average for both width and
length, lies between that of the nanodisc diameter and EGFR dimer length, while
length matches EGFR dimer data and width is slightly larger than empty nanodiscs.
This variability in distribution and larger than expected width suggests that the loaded
nanodisc sample may contain a complex mixture of different species, such as EGFR
monomers, EGFR dimers, nanodiscs with embedded EGFR monomers or dimers, as
well as interactions between nanodiscs and EGFR monomers without proper
embedding.
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E
Figure 17. Transmission electron micrographs of negatively stained proteins and nanodiscs. A. EGFR +
EGF proteins in all orientations; the inset is a possible EGFR dimer. B. Empty nanodiscs composed of
MSP1E3D1:EggPC 2:600. Note dense aggregates (dark) and nonhomogeneous size of nanodiscs, as
indicated by the inset. C. Empty nanodiscs composed of MSP1E3D1:EggPC 2:150. The nanodiscs are
not aggregated and are more homogenous is size. D. EGFR+EGF loaded nanodiscs composed of
MSP1E3D1:EggPC 2:150. This sample contains empty nanodiscs, proteins and loaded nanodiscs. The
inset displays a nanodisc that is labeled with streptavidin nanogold, indicating the presence of SBPtagged EGFR. E. A selection of potentially loaded nanodiscs. Note the asymmetrical shapes associated
with each nanodisc. Scale = 200nm.
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Figure 18. Distribution of all measurements for “aggregates”, empty nanodiscs, EGFR homodimers, and
nanodiscs loaded with EGFR. A. Lipid-rich nanodiscs with excess lipids show a broad distribution indicating
a wide variability in sizes. These results are in accordance with those seen with size exclusion and native
western blot. B. Empty nanodiscs with an MSP to lipid ratio of 2:150 display less variability in size based on
the histogram, with an average diameter of 12.4 nm per nanodisc, which is similar to published diameter of
nanodiscs assembled with MSP1E3D1. C. EGFR dimer measurements show a bimodal distribution where
the first normal distribution corresponds to measurements of width and the second to measurements of
length. The average size for these EGFR dimers is 20.9 nm in length and 10.5 nm is width, which is very
similar to the measurements published by Mi et al., 2008. D. Nanodiscs loaded with EGFR dimers show a
broad distribution, which suggests a complex mixture of different structures. The average for all
measurements is between that of a nanodisc diameter and EGFR dimer length. The average length of
sample matches EGFR dimer data. The average width is slightly larger than empty nanodiscs, and
significantly larger than EGFR dimer width.
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3.2.5. TIRF imaging of EGFR-nanodisc complexes
Advanced microscopy techniques have been also used to image nanodiscs in assays
that involve receptor activation, and controlled nanodisc and protein reconstitution
(Lamichhane
Raschle

et

et

Lamichhane

al.,
al.,

et

2017;
2015).

al.

study

conformational transitions of G
protein-coupled
nanodiscs
molecule

receptors

using
assay

a

in

single

based

on

nanodisc assembly with 5%
biotinylated lipids that bind a
coverslip

treated

with

neutravidin. In our work, we
Figure 19. SiMPull array functionalization for single-nanodisc
imaging. Nanodiscs were labelled after pulldown using α-His
AF488 (green) and α-EGFR AF647 (clone R-1) (red). A.
biotinylated α-EGFR glass (purple) functionalization to
pulldown EGFR-embedded nanodiscs. The use of PEG
(orange) and Avidin (light blue) allows for perfect orientation
of biotinylated α-EGFR. B. PEG and Avidin orient a biotinylated
α-His tag antibody (blue) on functionalized glass. This arrange
allows for pulldown of His-tagged MSP belt proteins
surrounding empty and EGFR-embedded nanodiscs. C. Use
of NeutrAvidin as a direct pull-down method for SBP-tagged
EGFR.

propose a different approach
based

on

coverslip

functionalization

through

neutravidin

and

biotinylated

antibodies followed by pull-down
of nanodisc complexes using the

His-tag on the MSP belt protein or the SBP-tag on the embedded receptor. These
bound complexes are then labelled using dyes or fluorescently conjugated antibodies
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and imaged using Total Internal Reflection Microscopy (TIRF).

An assembled

nanodisc with embedded receptors should show colocalization of receptor and
nanodisc to single molecule spots imaged on the surface of the coverslip. In this study
we focused on efficient surface functionalization that allowed nanodisc pull-down via
embedded EGFR or MSP belt protein with subsequent detection of receptor and
nanodisc using fluorescently-conjugated primary antibodies.
We used standard SiMPull techniques (Salazar-Cavazos et al., 2018) to functionalize
2x2 arrays. These arrays were functionalized using a mixture of Biotin-PEG and
mPEG. Each area on the array was later treated with Neutravidin and a biotinylated
antibody. We tested three different ways to bind nanodiscs to the surface, as well as
two ways to label the nanodiscs and the embedded protein. Biotinylated antibodies
against EGFR were used to pull-down EGFR, or antibodies against the His-tag were
used to capture the nanodiscs (Figure 19A and 19B). Neutravidin was also tested for
direct binding of the SBP-tag on the EGFR full-length receptor (Figure 19C).
Nanodiscs were labelled in-situ after they were pulled down. Initially, DiD (642
excitation) and α-EGFR XP AF555 were used to label the nanodisc lipid membrane
and EGFR, respectively. However, DiD was binding non-specifically to the coverslip
and creating a high background in both channels. To avoid lipid dyes usage, α-His
AF488 and α-EGFR AF647 (clone R-1) were used instead to label His-tagged
MSP1E3D1 and EGFR, respectively.
Empty nanodisc and loaded nanodisc samples were imaged, as well as a series of
controls including PEG-treated coverslips, functionalized coverslips with biotinylated
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his-tag antibody, pre-assembled empty nanodiscs (Cube Biotech – 26311), and free
EGFR on functionalized areas of the array.
Figures 20 – 22 show images of areas with samples and controls on biotinylated αHis-tag coverslips obtained through TIRF microscopy using 488 and 642 lasers.
Figure 20 shows two SiMPull functionalization controls for biotinylated α-His pulldown. Figure 20A corresponds to two separate areas within the same control sample,
a PEG functionalized coverslip with no α-His-tag functionalization. This control
provided information on the general noise to expect per area based on PEG
treatment. There are a few low intensity spots, particularly on the 642 channel,
indicating background autofluorescence from PEG treatment. Figure 20B
corresponds to a coverslip after α-His functionalization with no sample added. The
image shows some low intensity spots in the 642 channel, which can be attributed to
the coverslip treatment background fluorescence.
We tested purified EGFR (monomers), as well as pre-assembled MSP1D1 empty
nanodiscs from CubeBiotech (Figure 21). Figure 21A shows two different areas of
biotinylated α-His functionalized coverslip with free EGFR as a control. α-EGFR Af647
signal can be observed on the 642 channel corresponding to EGFR on the bottom of
the coverslip, which could occur due to non-specific binding or neutravidin affinity
pull-down of SBP-tagged EGFR. Compared to the other controls, high density and
signal can be observed in the 642 channel, while the 488 channel shows very low
noise. Figure 21B corresponds to pre-assembled MSP1D1 nanodisc samples from
CubeBiotech on an α-His functionalized coverslip. These nanodiscs are assembled
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with two 6x his-tagged MSP belt proteins, which should bind to the biotinylated α-His
antibody and are then labelled with α-His AF488. The images show that pull-down
through this antibody is not highly efficient. However, defined spots of bright signal
are visible on the 488 channel and are likely nanodiscs. Despite the fact that the 642
channel shows some fluorescence, there is no colocalization visible between any of
the nanodiscs and the signal on the 642 channel. Therefore, this unexpected
fluorescence on the 642 channel can be attributed to the coverslip functionalization.
Given this information from the controls, we expected some noise in the 642 channel
for the empty and loaded nanodisc samples in Figure 22. Figure 22A shows empty
nanodiscs of a 2:150 MSP to lipid ratio on α-His -functionalized coverslip. Pull down
efficiency is not high, which yields a small amount of visible nanodiscs, this could
directly relate to the α-His antibody used for pulldown or could also be due to
degradation of the nanodisc sample, given the presence of liposomes visible in
solution. A higher amount of unexpected signal on the 642 channel can be observed,
but after image analysis none of this signal colocalizes with the observed nanodiscs.
This unexpected signal on the 642 channel can be attributed to coverslip
functionalization or potential nonspecific binding of the α-EGFR Af647 fluorescent
antibody. Figure 22B corresponds to two areas of an α-His functionalized coverslip
with EGF-treated EGFR-loaded nanodiscs. Again, pull down efficiency is rather low,
which yields a small number of visible nanodiscs. However, one of the main
differences between this sample and the empty nanodisc sample is that a large
number of defined spots are present in the 642 channel, which indicates a high
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presence of EGFR. As with the EGFR only control, this could happen due to affinity
pull-down of SBP-tagged EGFR by available neutravidin sites. This large amount of
EGFR indicates that the majority of the target protein in the sample is not getting
incorporated into nanodiscs. This could be solved by assembling nanodiscs using a
smaller amount of lipid molecules to increase the space for the receptor within the
nanodisc, thereby increasing embedding efficiency. Moreover, Figure 22B shows
colocalization of EGFR and His-tagged MSP1E3D1 in the 642 and 488 channels,
respectively (marked by arrows on the merged image). This colocalization indicates
EGFR embedding in these nanodiscs.
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Figure 20. Single-nanodisc imaging controls for biotinylated α-His functionalization. A. PEG-only functionalized
coverslip shows general low intensity background autofluorescence from PEG treatment. B. α-His
functionalized coverslip shows noise on the 642 channel of low intensity attributed to treatment.
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Figure 21. Single-molecule imaging of EGFR monomers and pre-assembled MSP1D1 empty nanodiscs. A. αHis functionalized coverslip with free EGFR labelled with α-EGFR Af647. EGFR can be observed on the 642
channel due to neutravidin affinity pull-down of SBP-tagged EGFR. B. α-His functionalized coverslip with preassembled MSP1D1 nanodiscs from CubeBiotech labelled with α-His AF488. Low density of nanodiscs visible
indicates that pull-down is not highly efficient. Unexpected signal on the 642 channel shows no colocalization
with the nanodiscs and the signal on the 642 channel.
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Figure 22. Single-nanodisc imaging of empty and loaded nanodiscs A. Empty nanodiscs at a 2:150
MSP1E3D1 to EggPC ratio pulled down using biotinylated α-His antibody. Low pulldown efficiency could be
due to degradation of the nanodisc sample. More noise in the 642 channel is visible, but none colocalizes
with the nanodiscs. B. Nanodiscs loaded with EGFR dimers. A small number of nanodiscs is visible in the
488 channel. High numbers of EGFR are visible in this sample possibly due to affinity pull-down of the SBPtag by neutravidin. Colocalization within the two channels is marked by arrows, suggesting the presence of
EGFR-embedded nanodiscs.
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CHAPTER 4: CONCLUSIONS
Membrane receptors are responsible for a series of signaling pathways that are
directly related to basic cell functions. These pathways are triggered by mechanisms
whose structure is not fully understood. Protein structural studies provide information
that reveals the structure-function relationship behind receptor interactions. Through
this work, we focused on two RTKs that are expressed in different tissues and are
responsible for a number of cell functions, EGFR and RON. EGFR is a membrane
receptor that regulates cell functions, such as apoptosis, migration, proliferation, and
differentiation. RON is a membrane receptor of the MET family that is responsible for
cell migration and proliferation. Both of these receptors have been shown to play a
role in cancer. Although the structure and consequence of EGFR homodimerization
have been extensively studied, there is evidence of crosstalk between EGFR and
other receptors, including RON, that is less explored. Aberrant trans-activation of
RON and EGFR due to crosstalk has been related to tumorigenesis, and although
these two receptors have been shown to co-immunoprecipitate, the structural
information behind this interaction remains unknown.
Protein structural studies are imperative to fully understand the function behind these
receptor interactions. However, these studies are oftentimes difficult to achieve due
to protein solubilization, which is key to maintaining target proteins in a functional
state. There are a few techniques to solubilize membrane proteins, which include the
use of detergents that form detergent-protein micelles and the use of lipid vesicles.
However, these techniques often interfere with a number of assays and optical
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techniques, reduce protein activity, and may lead to denaturation. Nanodisc are an
excellent tool for structural studies, providing a native-like environment of
homogeneous size to embed membrane proteins that prevents aggregation and
maintains the receptor’s conformation and functionality.
This work focused on developing a nanodisc assembly protocol to achieve
embedding of full-length RON and/or EGFR, as well as finding alternative methods for
detection of embedded nanodiscs.
Nanodiscs have been used before to solubilize a number of proteins, including EGFR.
Our first aim was to optimize a nanodisc assembly protocol by manipulating nanodisc
size and lipid content to allow embedding of EGFR or RON into nanodiscs.
To achieve this, we needed a method to generate enough recombinant protein for
nanodisc incorporation. One of the biggest challenges behind the production of
functional membrane protein is the need for correct processing of proteins. While
bacteria can produce high yields of membrane proteins, it is not uncommon that the
proteins produced are not folded properly. Functional membrane proteins are
imperative for structure-function studies, and proper processing and folding is only
achieved using mammalian cells which generally have a low protein yield. In the
beginning of this work, our recombinant target proteins had been expressed in
HEK293 cells, and the purification process required further concentration of the
eluate, which in turn yielded enough protein for only one nanodisc preparation. This
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hindered the possibility to run other controls during each preparation, such as
embedding on different MSP-lipid ratios as well as purified EGFR (no nanodisc).
To increase protein yields, we transiently transfected our recombinant proteins in the
Expi293F cell line. These cells are HEK293 modified cells that grow in suspension,
increasing protein yields. This cell line increased protein production for full length
EGFR as well as RON fragments. Initially, full-length RON was not processed correctly
through this cell line. This means that RON was unable to properly get cleaved and
transported to the membrane. To stop protein translation and thus reduce the
concentration of pro-RON in the cells, we treated the cells with CHX, reducing the
pro-RON:RON ratio from 1:1 to 1:4 in the lysate.
We based our preliminary studies on previous work by Mi et al 2008, where EGFR is
embedded in MSP1D1-DMPC nanodiscs. These experiments appeared to be
successful based on native-PAGE results. However, we resolved that given the size
of our target receptors, the use of larger nanodiscs could facilitate and perhaps
increase receptor embedding. Similarly, based on molecular dynamics modeling
studies from collaborators, we concluded that using a lipid with longer carbon chains
would increase nanodisc height and potentially be beneficial for proper embedding of
the transmembrane domain, as well as helping avoid unwanted interactions between
the MSP belt protein and the embedded membrane receptor.
We tested nanodisc assembly using MSP1E3D1, a longer version of MSP1D1, as well
as EggPC, a natural lipid mixture of mostly POPC, a 16-carbon chain lipid. To obtain
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the optimal MSP to lipid ratio, we tested the assembly of different nanodiscs with an
increasing number of lipid molecules per belt protein, including nanodiscs with lipid
excess (2:600). It was determined that the optimal MSP:lipid ratio was 2:150. EGFR
incorporation was tested on nanodiscs with MSP:lipid ratios of 2:100 and 2:150,
where EGFR and EGF-treated EGFR incorporation was observed via native-PAGE in
both cases, respectively. Despite these results, it was clear that complementary
methods of analysis that would allow us to determine nanodisc embedding were
needed.
One of the methods that is commonly described in previous work is size exclusion
chromatography. In this case, nanodiscs assemblies are run through a size exclusion
column that separates loaded from empty nanodiscs, as well as raw components,
such as MSP belt protein and target protein, that have not been incorporated. Size
exclusion chromatography provided information regarding EGFR incorporation into
nanodiscs by showing distinct peaks for empty and embedded nanodiscs. However,
previous work suggests that the fractions must be recovered and analyzed by SDSPAGE to obtain definitive information for embedding. In our case, these fractions were
too dilute to be detected via western blot.
Since our nanodisc preparations were relatively smaller than those reported by
previous work, we attempted to determine a method that would be more suitable to
detect nanodisc incorporation in smaller nanodisc assembly preparations. We
attempted to use affinity precipitation to pull-down the nanodiscs using the His-tag on
the MSP belt protein. After pull-down the resin was denatured and analyzed via SDS-
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PAGE. Despite the presence of EGFR in the “loaded” nanodisc samples, we
discovered this was due to nonspecific binding of EGFR to the Ni-NTA resin, thus
deeming it impossible to determine if the nanodiscs contained receptor or not.
We also tested EGFR immunoprecipitation to pull-down loaded nanodiscs. Similar
techniques have been reported in previous work, in which a target protein with a tag
is pulled down via affinity. In our case, we used agarose resin conjugated with an
EGFR antibody to pull-down on EGFR-embedded nanodiscs. However, our controls
showed that despite the good binding of EGFR, there was nonspecific binding of
empty nanodiscs to the resin. In our opinion, despite our unfavorable results for affinity
precipitation and immunoprecipitation of embedded nanodiscs, this is a method that
should be further explored to obtain an approximation of embedded nanodiscs in
small preparations.
We used EM and negative staining to image purified EGFR, empty nanodiscs, and
loaded nanodiscs to observe any structural differences between the samples that
could provide information on nanodisc embedding, as well as general sizes for the
structures found within each sample. According to our results, EGFR and EGF-treated
EGFR show distinct sizes and structures that are similar to those reported in previous
work. Our empty nanodisc assemblies show a homogeneous size and a distinct
circular structure and an average diameter of around 12.4 nm, which concurs with
the size reported for MSP1E3D1. Our loaded nanodisc samples show a variety of
different structures, including empty nanodiscs and non-embedded EGFR. Despite
the low yield of loaded nanodiscs some structures appear to be nanodiscs with
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embedded protein. Therefore, visual inspection of nanodiscs samples is a useful
method for determining the extent of protein incorporation using only a small amount
of sample.
An unexpected finding originates from EM imaging of “aggregates” or lipid-rich
nanodiscs of 2:600 MSP-lipid ratio. These excess-lipid complexes display the
appearance of larger nanodiscs of heterogeneous size. This poses an interesting
question regarding the organization of the MSP belt protein that allows it to associate
with other MSPs to generate longer MSP- complexes that surround a larger amount
of lipids.
We also tested protocols for single molecule imaging of nanodisc-EGFR complexes.
To achieve this, we functionalized the surface of coverslips with neutravidin to prompt
the correct orientation of biotinylated antibodies through affinity. These antibodies
were used to pull-down either His-tagged MSP belt proteins or EGFR. The nanodiscs
and receptors were labelled by using fluorescent antibodies. Using TIRF microscopy,
we were able to define individual molecules which allowed us to find colocalization
between EGFR and the nanodiscs. Finding colocalization allowed us to determine that
embedding efficiency was low and that the majority of the EGFR was not incorporated
in nanodiscs. This showed us that the EGFR:nanodiscs ratio can be reduced in future
preparations, which will use less EGFR protein. Also, it may be helpful to reduce the
amount of lipids per nanodisc, as this could provide more “space” for receptors to
insert more efficiently.
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Through this study we attempted to find new methods to reliably detect nanodisc
embedding for smaller preparations. One of the most relevant findings includes the
combination of techniques that provide information on nanodiscs quality (EM) and
embedding efficiency (single molecule microscopy), while using small sample
amounts. The use of these techniques allows to reduce nanodisc “trial and error” that
comes with deciphering the number of lipid molecules per MSP based on the size of
the target protein.
In conclusion, the techniques used throughout this work are intended to better
understand the behavior of nanodiscs and how these self-assembled complexes are
affected depending on the size of the target protein to incorporate. In particular, I have
1) established protein purification protocols using the new Expi293 cells that provide
a higher yield of protein; 2) determined the proper choice of MSP belt protein and lipid
composition for larger transmembrane complexes; and 3) shown that a combination
of EM and single molecule imaging provided a useful approach to characterizing
nanodisc samples while using a small sample size. This research sets the precedent
for the development of techniques that allow us to properly identify and optimize
receptor embedding into nanodiscs for further structural studies.
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CHAPTER 5: FUTURE DIRECTIONS
Based on the information collected through EM and single-molecule imaging, we
found that a high fraction of the EGFR is not being incorporated during nanodisc
assembly. This could be due to an excessive amount of lipid molecules per nanodisc,
given the fact that upon receptor embedding, these lipid molecules will be displaced
by the transmembrane domain. The results suggest that although there are some
loaded nanodiscs, the amount of lipid in the nanodisc mixture may not allow the
membrane receptor to incorporate due to the lack of space within the nanodisc. It is
necessary to go back and attempt nanodisc assembly with a slightly reduced amount
of lipid molecules to increase embedding efficiency.
Given the results obtained through affinity precipitation, it is clear that improving this
method could make it a great tool to determine receptor embedding. This technique
could be easily applied to small nanodisc preparations and would expand on the
results obtained through native-PAGE. A possible experiment that could broaden this
technique is the use of streptavidin resin for affinity precipitation of SBP-tagged EGFR
embedded in nanodiscs. After pull-down, the resin could be denatured by boiling and
the supernatant containing the proteins bound could be analyzed by SDS-PAGE, this
would help determine target protein incorporation by showing the presence of MSP
belt protein along with pull-down EGFR.
Affinity precipitation using streptavidin resin to pull-down on embedded EGFR could
provide cleaner samples for imaging. One of the benefits of streptavidin affinity
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precipitation is the fact that it involves gentle elution, that is, bound proteins can be
eluted from the streptavidin resin without the use of detergents or imidazole that could
potentially affect the integrity of nanodiscs. The presence of biotin from the target
protein eluate so far has shown no direct effects on nanodisc assembly. Therefore,
streptavidin affinity precipitation of EGFR-embedded nanodiscs and consecutive
elution using biotin could decrease the number of empty nanodiscs in the sample,
thus increasing the probability of finding loaded nanodiscs during single molecule
imaging and EM.
The goal of this work was to establish a protocol that would make nanodisc assembly
and receptor embedding detection a reliable process for structural studies of
membrane proteins. We have determined a work flow for purification of recombinant
protein, nanodisc-protein incorporation, and characterization of the nanodisc sample.
Ultimately, this work sets the precedent for future studies in our group of EGFR and
RON homodimers and heterodimers within a single nanodisc.
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